Possible role of catheters in Saccharomyces boulardii fungemia

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 19, Issue 1, 2000, Pages 16-20

  Hennequin, C ^a,c   Kauffmann Lacroix, C ^b   Jobert, A ^a   Viard, J P ^a   Ricour, C ^a   Jacquemin, J L ^b   Berche, P ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b POITIERS UNIVERSITY HOSPITAL   (France)

^c AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE;

ADULT; AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIARRHEA; FEMALE; FUNGEMIA; HUMAN; INDWELLING CATHETER; MALE; MEDICAL LITERATURE; PARENTERAL NUTRITION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTECTIVE CLOTHING; SACCHAROMYCES BOULARDII; SEPTIC SHOCK;

EID: 0006088806     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100960050003     Document Type: Article

References (20)

1. 1. Fridkin SK, Jarvis WR: Epidemiology of nosocomial fungal infections. Clinical Microbiology Reviews (1996) 9:499-511
2. 2. Hazen K: New and emerging yeast pathogens. Clinical Microbiology Reviews (1995) 8:462-478
3. 3. McCullough MJ, Clemons KV, McCusker JH, Stevens DA: Species identification and virulence attributes of Saccharomyces boulardii (nom. inval.). Journal of Clinical Microbiology (1998) 36:2613-2617
4. 4. McFarland LV, Bernasconi P: Saccharomyces boulardii: a review of an innovative biotherapeutic agent. Microbial Ecology in Health and Disease (1993) 343:171-172
5. 5. Bleichner G, Blehaut H, Mentec H, Moyse D: Saccharomyces boulardii prevents diarrhea in critically ill tube-fed patients. A multicenter, randomized, double-blind placebo-controlled trial. Intensive Care Medicine (1997) 23:517-523
6. 6. McFarland LV: Saccharomyces boulardii is not Saccharomyces cerevisiae. Clinical Infectious Diseases (1996) 22:200-201
7. 7. Larrone DH: Medically important fungi. A guide to identification. ASM Press, Washington DC (1995) p 254
8. 8. Guillamon JM, Barrio E, Huerta T, Querol A: Rapid characterization of four species of the Saccharomyces sensu stricto complex according to mitochondrial DNA patterns. International Journal of Systematic Bacteriology (1994) 44:708-714
9. 9. Zunic P, Lacotte J, Pegoix M, Buteux G, Leroy G, Mosquet B, Moulin M: Fongémie à Saccharomyces boulardii. A propos d'un cas. Therapie (1991) 46:498-499
10. 10. Viggiano M, Badetti C, Bernini V, Garabedian M, Manelli J: Fongemie à Saccharomyces boulardii chez un brulé grave. Annales Française d'Anesthésie Réanimation (1995) 14:356-358
11. 11. Pletincx M, Legein J, Vandenplas Y: Fungemia with Saccharomyces boulardii in a 1-year-old girl with protracted diarrhea. Journal of Pediatric Gastroenterology and Nutrition (1995) 21:113-115
12. 12. Fredenucci I, Chomarat M, Boucaud C, Flandrois J: Saccharomyces boulardii fungemia in a patient receiving Ultra-Levure therapy. Clinical Infectious Diseases (1998) 27:222-223
13. 13. Boucaud C, Berrada K, Bouletreau P: Septicémie à Saccharomyces boulardii après administration orale d'ultra-levure. Réanimation Urgences (1996) 5:665
14. 14. Basseti S, Frei R, Zimmerli W: Fungemia with Saccharomyces cerevisiae after treatment with Saccharomyces boulardii. American Journal of Medicine (1998) 105:71-72
15. 15. Niault M, Thomas F, Prost J, Hojjat Ansari F, Kalfon P: Fungemia due to Saccharomyces species in a patient treated with enteral Saccharomyces boulardii. Clinical Infectious Diseases (1999) 28:930
16. 16. Piarroux R, Millon L, Bardonnet K, Vagner O, Koenig H: Are live Saccharomyces yeasts harmful to patients? Lancet (1999) 353:1851-1852
17. 17. Cimolai N, Gill MJ, Church D: Saccharomyces cerevisiae fungemia: case report and review of the literature. Diagnostic Microbiology and Infectious Disease (1987) 8:113-117
18. 18. Kralovicova K, Spanik S, Oravcova E, Mrazova M, Morova E, Gulikova V, Kukuckova E, Koren P, Pichna P, Nogova J, Kunova A, Trupl J, Krcmery VJ: Fungemia in cancer patients undergoing chemotherapy versus surgery: risk factors, etiology and outcome. Scandinavian Journal of Infectious Diseases (1997) 29:301-304
19. 19. Zerva L, Hollis RJ, Pfaller MA: In vitro susceptibility testing and DNA typing of Saccharomyces cerevisiae clinical isolates. Journal of Clinical Microbiology (1996) 34:3031-3034
20. 20. Blehaut H, Massot J, Elmer GW, Levy RH: Disposition kinetics of Saccharomyces boulardii in man and rat. Biopharmaceutics and Drug Disposition (1989) 10:353-364